The CONSENSUS Trial Study Group.Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).N Engl J Med1987; 316: 1429–35.
2.
The SOLVD Investigators.Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.N Engl J Med1991; 325: 293–302.
3.
RutherfordJ.D., PfefferM.A., MoyeL.A.Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.Circulation1994; 90: 1731–8.
4.
GargR., YusufS.Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.JAMA1995; 273: 1450–6.
5.
CIBIS II Investigators and Committees.The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomized trial.Lancet1999; 353: 9–13.
6.
MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).Lancet1999; 353: 2001–7.
7.
McMurrayJ., KøberL., RobertsonM.Antiarrhythmic effect of carvedilol after acute myocardial infarction. Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) Trial.J Am Coll Cardiol2005; 45: 525–30.
8.
SwedbergK., ClelandJ., DargieH.Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology: Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005).Eur Heart J2005; 26: 1115–40.
9.
The Beta-Blocker Heart Attack Research Group.A randomized trial of propranolol in patients with acute myocardial infarction: I Mortality results.JAMA1982; 247: 1707–14.
10.
PackerM., CarverJ.R., RodehefferT.J., for the Promise Study Research Group. Effect of oral milirinone on mortality in severe chronic heart failure.N Engl J Med1991; 325: 1468–75.
11.
ZipesD.P., RubartM.Neural modulation of cardiac arrhythmias and sudden cardiac death.Heart Rhythm2006; 3: 108–13.
ChenP-S, ChenL.S., SharifiB.Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death.Cardiovasc Res2001; 50: 409–16.
14.
SpinaleF.G., de GasparoM., WhitebreadS.Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. I. Effects on left ventricular performance and neurohormonal systems.Circulation1997; 96: 2385–96.
15.
KimS., IwaoH.Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.Pharmacol Rev2000; 52: 11–34.
16.
BélichardP., SavardP., CardinalR.Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias.J Am Coll Cardiol1994; 23: 505–13.
17.
ClelandJ.G., Cohen-SolalA., AguilarJ.C.IMPROVEMENT of Heart Failure Programme Committees and Investigators: Improvement programme in evaluation and management; Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.Lancet2002; 360: 1631–9.
18.
LeeD.S., TuJ.V., JuurlinkD.N.Risk-treatment mismatch in the pharmacotherapy of heart failure.JAMA2005; 294: 1240–7.
19.
WillenheimerR., van VeldhuisenD.J., SilkeB., on behalf of the CIBIS-III investigators. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence. Results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.Circulation2005; 112: 2426–35.
20.
Data presented at the Hot Line session of the ESC meeting Barcelona 2006.
21.
BrodineW.N., TungR.T., LeeJ.K.Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II).Am J Cardiol2005; 96: 691–5.
